Algert Global’s Axonics, Inc. Common Stock AXNX Stock Holding History

Algert Global’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-73,627	Closed	-$5.12M	–	1370
2024 Q3	$5.12M	Buy	73,627 +39,780	+118%	+$2.73M	0.14%	248
2024 Q2	$2.28M	Buy	33,847 +6,978	+26%	+$470K	0.08%	428
2024 Q1	$1.85M	Sell	26,869 -5,030	-16%	-$339K	0.07%	435
2023 Q4	$1.99M	Buy	31,899 +8,499	+36%	+$475K	0.08%	422
2023 Q3	$1.31M	Buy	+23,400	New	+$1.32M	0.06%	503

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Algert Global's AXNX Position: Q4 2024 in Review

Algert Global sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 73,627 shares — an estimated $5.12M sold.

Algert Global first reported a position in AXNX in Q3 2023 and held it in 5 quarters. The position peaked at $5.12M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Algert Global reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Algert Global sold 73,627 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $5.12M.
Algert Global first reported a position in Axonics, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
Algert Global's Axonics, Inc. Common Stock position peaked at $5.12M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.